June 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountcalquencehcp.com
Global Rank
#3,280,080
279,118Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
73.22%
Pages per Visit
1.50
Avg Visit Duration
00:00:21
- Company
- - -
- Industry
- - -
Top 10 calquencehcp.com Competitors
The Top 10 Sites Like calquencehcp.com in June 2026 are ranked by their affinity to calquencehcp.com in terms of keyword traffic, audience targeting, and market overlap
Find specialty pharmacy info to help patients access XALKORI®, an Rx treatment option for ALK-positive or ROS1-positive metastatic NSCLC. See risks & benefits.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
100%
Pages per Visit
1.00
Avg Visit Duration
- -
Similarity Score
100%Safety profile of ADCETRIS® (brentuximab vedotin)+AVEPC, including possible side effects and BOXED WARNING, for patients with high-risk pediatric cHL.
- Company
- - -
- Industry
- - -
Bounce Rate
59.08%
Pages per Visit
1.45
Avg Visit Duration
00:00:23
Similarity Score
98%View the official IMBRUVICA® (ibrutinib) patient website. See full Prescribing & Safety Information.
- Company
- - -
- Industry
- - -
Global Rank
#3,268,654
128,358Bounce Rate
80.21%
Pages per Visit
1.31
Avg Visit Duration
00:00:16
Similarity Score
95%Learn about TUKYSA® (tucatinib). See safety info.
- Company
- - -
- Industry
- - -
Bounce Rate
63.83%
Pages per Visit
1.35
Avg Visit Duration
00:02:07
Similarity Score
93%Hear from expert doctors as they discuss overall liver health, hepatocellular carcinoma (HCC), and treatment with TECENTRIQ® (atezolizumab) and Avastin® (bevacizumab) as a combination treatment option. See full safety for more information.
- Company
- - -
- Industry
- - -
Global Rank
#2,402,034
486,496Bounce Rate
63.84%
Pages per Visit
1.48
Avg Visit Duration
00:00:25
Similarity Score
92%- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
43.15%
Pages per Visit
3.39
Avg Visit Duration
00:00:52
Similarity Score
91%TRUQAP™ (capivasertib), a prescription medication in combination with fulvestrant that is targeted for patients with HR+/HER2- breast cancer with one or more PIK3CA/AKT1/PTEN -alteration.
- Company
- - -
- Industry
- - -
Bounce Rate
67.03%
Pages per Visit
1.27
Avg Visit Duration
00:00:40
Similarity Score
89%Review symptoms of BPDCN, including skin-related issues and the role of CD123 in disease diagnosis. See full Prescribing Information, including Boxed WARNING.
- Company
- - -
- Industry
- - -
Bounce Rate
68.15%
Pages per Visit
1.69
Avg Visit Duration
00:00:19
Similarity Score
88%This Cookie Policy explains how Geron Corporation uses cookies and similar technologies when you visit our website or any other site that links to this Cookie Policy.
- Company
- - -
- Industry
- - -
Bounce Rate
76.63%
Pages per Visit
1.40
Avg Visit Duration
00:01:10
Similarity Score
87%Learn about the FIREFLY-1 clinical study. Please see Important Safety Information and full Prescribing Info.
- Company
- - -
- Industry
- - -
Bounce Rate
70.22%
Pages per Visit
1.49
Avg Visit Duration
00:00:47
Similarity Score
86%calquencehcp.com's top 5 competitors in June 2026 are: xalkori.pfizerpro.com, adcetrispro.com, imbruvica.com, tukysa.com, and more.
According to Similarweb data of monthly visits, calquencehcp.com’s top competitor in June 2026 is xalkori.pfizerpro.com. calquencehcp.com 2nd most similar site is adcetrispro.com, and closing off the top 3 is imbruvica.com.
tukysa.com ranks as the 4th most similar website to calquencehcp.com and tecentriq.com ranks fifth in June 2026.
The other five competitors in the top 10 list are verzenio.lilly.com, truqaphcp.com, elzonris.com, rytelo.com, and ojemda.com.